Early or deferred treatment of smoldering multiple myeloma: a meta-analysis on randomized controlled studies.

Zhao, Ai-Lin; Shen, Kai-Ni; Wang, Ji-Nuo; Huo, Lan-Qing; Li, Jian; Cao, Xin-Xin

Zhao, Ai-Lin; Shen, Kai-Ni; Wang, Ji-Nuo; Huo, Lan-Qing; Li, Jian; Cao, Xin-Xin.

Afiliação

Zhao AL; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Shen KN; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Wang JN; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Huo LQ; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Li J; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Cao XX; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

Cancer Manag Res ; 11: 5599-5611, 2019.

Article em En | MEDLINE | ID: mdl-31296995

Palavras-chave

early treatment; lenalidomide; meta-analysis; smoldering multiple myeloma

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Revista: Cancer Manag Res Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google